| pubmed-article:7977168 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0334277 | lld:lifeskim |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0338106 | lld:lifeskim |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0011015 | lld:lifeskim |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:7977168 | lifeskim:mentions | umls-concept:C0592528 | lld:lifeskim |
| pubmed-article:7977168 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:7977168 | pubmed:dateCreated | 1994-12-21 | lld:pubmed |
| pubmed-article:7977168 | pubmed:abstractText | Liposomal encapsulation of drugs can potentially ameliorate toxicities and improve acute and chronic tolerance. The increased uptake of liposomes by colon adenocarcinoma cell lines may enable DaunoXome to circumvent the p-glycoprotein-mediated anthracycline resistance of colon cancer cells. | lld:pubmed |
| pubmed-article:7977168 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7977168 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977168 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7977168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977168 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7977168 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:7977168 | pubmed:issn | 0277-3732 | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:CampbellEE | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:BurrisH AHA | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:CoboEE | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:RothenbergM... | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:WeissG RGR | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:RodriguezG... | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:EckardtJ RJR | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:FieldsS MSM | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:PeacockN WNW | lld:pubmed |
| pubmed-article:7977168 | pubmed:author | pubmed-author:ThurmanA MAM | lld:pubmed |
| pubmed-article:7977168 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7977168 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:7977168 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7977168 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:7977168 | pubmed:pagination | 498-501 | lld:pubmed |
| pubmed-article:7977168 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:meshHeading | pubmed-meshheading:7977168-... | lld:pubmed |
| pubmed-article:7977168 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7977168 | pubmed:articleTitle | A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon. | lld:pubmed |
| pubmed-article:7977168 | pubmed:affiliation | University of Texas Health Science Center, San Antonio. | lld:pubmed |
| pubmed-article:7977168 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7977168 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7977168 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7977168 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7977168 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7977168 | lld:pubmed |
